# Buymed Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/buymed-pte

- Industry: Retail
- Headquarters: Ho Chi Minh City, Vietnam
- Website: www.thuocsi.vn
- Total disclosed funding: $64M
- Latest round: Series B (May 2, 2023)
- Investors on record: 9

## About

Based in Vietnam, Buymed Pte. Ltd. operates thuocsi.vn, a B2B e-commerce platform focused on the wholesale distribution of pharmaceutical products and medical supplies, enhancing accessibility for healthcare providers.Founded in 2018 and headquartered in Ho Chi Minh City, Vietnam, Buymed Pte. Ltd. focuses on digital solutions for pharmaceutical distribution. The company has garnered attention through a successful Series B funding round, raising USD 51.5 mn on May 2, 2023, led by UOB Venture Management with participation from other investors. The company was established by Vu Vuong, who brings prior entrepreneurial experience to this venture.Buymed operates thuocsi.vn, a B2B e-commerce platform that specializes in the wholesale distribution of pharmaceutical products, functional foods, and medical supplies. The platform provides a variety of health-enhancing products, such as probiotics and vitamins, tailored for pharmacies, clinics, and healthcare providers. The online marketplace facilitates efficient order management and logistics, serving a wide geographical area, including major cities like Ho Chi Minh City, Hanoi, and Bình Duong and partnering with over 200 international providers.In 2023, Buymed reported revenue of USD 4,514,215 with a negative EBITDA of USD -4,796,214. The company generates revenue primarily through B2B transactions, allowing healthcare providers to purchase pharmaceutical products and medical supplies at competitive wholesale prices, supported by an efficient logistics model.Following the recent Series B funding of USD 51.5 mn, Buymed plans to enhance its platform and infrastructure to support growth initiatives. The company aims to launch new product lines in the coming year and expand its market presence within Southeast Asia by targeting regions such as Thailand and Indonesia by 2024.

## Funding rounds

- Series B, May 2, 2023, $52M — U.S. International Development Finance Corporation, UOB Venture Management, Smilegate Investment, Cocoon Capital
- Series B, Aug 30, 2021, $8.9M — Smilegate Investment, B Capital, Genesia Ventures, Cocoon Capital, Nextrans, Surge, TSP Consulting
- Series A, Mar 24, 2020, $2.7M — Genesia Ventures, Cocoon Capital, Surge
- Seed, Jun 7, 2019, $0.6M — Cocoon Capital

## Investors

- Cocoon Capital (https://capitalatlas.ai/funds/cocoon-capital) — Seed, Series A, Series B
- Genesia Ventures (https://capitalatlas.ai/funds/genesia-ventures) — Series A, Series B
- Surge (https://capitalatlas.ai/funds/surge) — Series A, Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series B
- B Capital (https://capitalatlas.ai/funds/b-capital) — Series B
- Nextrans (https://capitalatlas.ai/funds/nextrans) — Series B
- TSP Consulting — Series B
- U.S. International Development Finance Corporation — Series B
- UOB Venture Management (https://capitalatlas.ai/funds/uob-venture-management) — Series B